Laura A. Vallow

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

Frank A. Vicini, Reena S. Cecchini, Julia White et al. · The Lancet · 2019 · 461 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +9

RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

Beryl McCormick, Kathryn Winter, Clifford A. Hudis et al. · Journal of Clinical Oncology · 2015 · 390 citations · Full text

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet · 2015 · 194 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +10

Prognostic factors in Merkel cell carcinoma: Analysis of 240 cases

Tina I. Tarantola, Laura A. Vallow, Michele Y. Halyard et al. · Journal of the American Academy of Dermatology · 2012 · 173 citations

Tumoral Pathology, Medicine, Pathology +5

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Patricia A. Ganz, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet · 2015 · 78 citations · Full text

Surgical Oncology, Patient-reported Outcomes, Breast Oncology +9